During the past decade, Uniwersyteckie Centrum Kliniczne; Klinika Hematologii i Transplantologii conducted 26 clinical trials. In the 10-year time frame, 26 clinical trials started and 14 clinical trials were completed, i.e. on average, 53.8% percent of trials that started reached the finish line to date. In the past 5 years, 15 clinical trials started and 6 clinical trials were completed. i.e. 40% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Uniwersyteckie Centrum Kliniczne; Klinika Hematologii i Transplantologii" #1 sponsor was "Hoffmann-La Roche" with 9 trials, followed by "Pfizer" with 8 trials sponsored, "Bio Products Laboratory" with 2 trials sponsored, "Janssen Research & Development, LLC" with 2 trials sponsored and "Maria Sklodowska-Curie National Research Institute of Oncology" with 2 trials sponsored. Other sponsors include 7 different institutions and companies that sponsored additional 17 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Uniwersyteckie Centrum Kliniczne; Klinika Hematologii i Transplantologii" #1 collaborator was "Chugai Pharmaceutical" with 4 trials as a collaborator, "KCRI" with 2 trials as a collaborator, "AbbVie" with 1 trials as a collaborator, "Fondazione Italiana Linfomi ONLUS" with 1 trials as a collaborator and "Janssen Biotech, Inc., including Johnson & Johnson" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 9 trials.

According to Clinical.Site data, the most researched conditions in "Uniwersyteckie Centrum Kliniczne; Klinika Hematologii i Transplantologii" are "Hemophilia A" (3 trials), "Hemophilia A or B" (2 trials), "Multiple Myeloma" (2 trials), "Paroxysmal Nocturnal Hemoglobinuria" (2 trials) and "ACUTE LYMPHOBLASTIC LEUKEMIA" (1 trials). Many other conditions were trialed in "Uniwersyteckie Centrum Kliniczne; Klinika Hematologii i Transplantologii" in a lesser frequency.

Most popular intervention types in "Uniwersyteckie Centrum Kliniczne; Klinika Hematologii i Transplantologii" are "Drug" (29 trials), "Biological" (7 trials), "Procedure" (2 trials), "Diagnostic Test" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Cyclophosphamide" (3 trials), "Placebo" (3 trials), "Rituximab" (3 trials), "Crovalimab" (2 trials) and "Dexamethasone" (2 trials). Other intervention names were less common.

The vast majority of trials in "Uniwersyteckie Centrum Kliniczne; Klinika Hematologii i Transplantologii" are 33 trials for "All" genders and 2 trials for "Male" genders.

Currently, there are 17 active trials in "Uniwersyteckie Centrum Kliniczne; Klinika Hematologii i Transplantologii". 2 are not yet recruiting, 10 are recruiting, 4 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 16 completed trials in Uniwersyteckie Centrum Kliniczne; Klinika Hematologii i Transplantologii, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Uniwersyteckie Centrum Kliniczne; Klinika Hematologii i Transplantologii, 3 "Phase 1" clinical trials were conducted, 15 "Phase 2" clinical trials and 16 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 0 trials that are defined as “Not Applicable".